Current Problems in Pediatric and Adolescent Health Care
Volume 38, Issue 2 , Pages 50-63 , February 2008

Environmental Genotoxicants/Carcinogens and Childhood Cancer: Filling Knowledge Gaps

References 

  1. Ebb DH, Green DM, Shamberger RC, et al. Solid tumors of childhood. In:  DeVita VT,  Hellman S,  Rosenberg SA editor. Cancer (Principles and Practice of Oncology). 6th Edition. Philadelphia: Lippincott Williams & Wilkins; 2001;p. 2169–2214
  2. Landrigan PJ, Suk WA, Amler RW. Chemical wastes, children’s health, and the Superfund Basic Research Program. Environ Health Perspect. 1999;107:423–427
  3. Suk WA, Murray K, Avakian MD. Environmental hazards to children’s health in the modern world. Mutat Res. 2003;544:235–242
  4. Wild CP, Kleinjans J. Children and increased susceptibility to environmental carcinogens: evidence or empathy?. Cancer Epidemiol Biomarkers Prev. 2003;12:1389–1394
  5. Kimmel GL. An overview of children as a special population—relevance to predictive biomarkers. Toxicol Appl Pharmacol. 2005;206:215–218
  6. Anderson LM, Diwan BA, Fear NT, Roman E. Critical windows of exposure for children’s health: cancer in human epidemiological studies and neoplasms in experimental animal models. Environ Health Perspect. 2000;108(Suppl 3):573–594
  7. Anderson LM. Predictive values of traditional animal bioassay studies for human perinatal carcinogenesis risk determinations. Toxicol Appl Pharmacol. 2004;199:162–174
  8. Steliarova-Foucher E, Stiller C, Kaatsch P, Berrino F, Coebergh J-W, Lacour B, et al. Geographical patterns and time trends of cancer incidence and survival among children and adolescents in Europe since the 1970s (the ACCIS project): an epidemiological study. Lancet. 2004;364:2097–2105
  9. Weidmann C, Black RJ, Masuyer E, Parkin DM. Incidence of non-Hodgkin’s lymphoma in children between 1970 and 1990 in nine European countries. Eur J Cancer. 1999;35:1235–1237
  10. Magnani C, Dalmasso P, Pastore G, Terracini B, Martuzzi M, Mosso ML, et al. Increasing incidence of childhood leukemia in northwest Italy. Int J Cancer. 2003;105:552–557
  11. McNally RJ, Cairns DP, Eden OB, Kelsy AM, Taylor GM, Birch JM. Temporal increases in the incidence of childhood solid tumors seen in Northwest England (1954-1998) are likely to be real. Cancer. 2001;92:1967–1976
  12. McNally RJ, Cairns DP, Eden OB, Kelsy AM, Taylor GM, Birch JM. Examination of temporal trends in the incidence of childhood leukaemias and lymphomas provides aetiological clues. Leukemia. 2001;15:1612–1618
  13. Birch JM, Alston RD, Kelsey AM, Quinn MJ, Babb P, et al. Classification and incidence of cancers in adolescents and young adults in England 1979-1997. Br J Cancer. 2002;87:1267–1274
  14. Stat Bite. Incidence of and mortality from childhood cancers, 1975-2000. J Natl Cancer Inst. 2004;95:1506
  15. Bunin GR. Nongenetic causes of childhood cancers: evidence from international variation, time trends, and risk factor studies. Toxicol Appl Pharmacol. 2004;199:91–103
  16. Smith MA, Freidlin B, Ries LA, Simon R. Trends in reported incidence of primary malignant brain tumors in the United States. J Natl Cancer Inst. 1998;90:1269–1277
  17. Linet MS, Ries LAG, Smith MA, Tarone RE, Devesa SS. Cancer surveillance series: recent trends in childhood cancer incidence and mortality in the United States. J Natl Cancer Inst. 1999;91:1051–1058
  18. Hjalgrim LL, Westergaard T, Rostgaard K, Schmiegelow K, Melbye M, Hjalgrim H, et al. Birth weight as a risk factor for childhood leukemia: a meta-analysis of 18 epidemiological studies. Am J Epidemiol. 2003;158:724–735
  19. Hjalgrim LL, Rostgaard K, Hjalgrim H, Westergaard T, Thomassen H, Forestier E, et al. Birth weight and risk for childhood leukemia in Denmark, Sweden, Norway, and Iceland. J Natl Cancer Inst. 2004;96:1549–1556
  20. Lee J, Chia KS, Cheung KH, Chia SE, Lee HP. Birth-weight and the risk of early childhood cancer among Chinese in Singapore. Int J Cancer. 2004;110:465–467
  21. Paltiel O, Harlap S, Deutsch L, Knaanie A, Massalha S, Tiram E, et al. Friedlander, Birth weight and other risk factors for acute leukemia in the Jerusalem perinatal study cohort. Cancer Epidemiol Biomarkers Prev. 2004;13:1057–1064
  22. Yeazel MW, Ross JA, Buckley JD, Woods WG, Ruccione K, Robison LL. High birthweight and risk of specific childhood cancers: a report from the Children’s Cancer Group. J Pediatr. 1997;131:671–677
  23. Von Behren J, Reynolds P. Birth characteristics and brain cancers in young children. Int J Epidemiol. 2003;32:248–256
  24. Heuch JM, Heuch I, Akslen LA, Kvale G. Risk of primary childhood brain tumors related to birth characteristics: a Norwegian prospective study. Int J Cancer. 1998;77:498–503
  25. McCormack VA, dos Santos SI, Koupil I, Leon DA, Lithell HO. Birth characteristics and adult cancer incidence: Swedish cohort of over 11,000 men and women. Int J Cancer. 2005;115:611–617
  26. Andersson SW, Bengtsson C, Hallberg L, Lapidus L, Niklasson A, Wallgren A, et al. Cancer risk in Swedish women: the relation to size at birth. Br J Cancer. 2001;84:1193–1198
  27. Waterland RA, Garza C. Potential mechanisms of metabolic imprinting that lead to chronic disease. Am J Clin Nutr. 1999;69:179–197
  28. McNally RJQ, Eden TOB. An infectious aetiology for childhood acute leukemia: a review of the evidence. Br J Haematol. 2004;127:243–263
  29. Stolt A, Kjellin M, Sasnausakas K, Luostarinen T, Koskela P, Lehtinen M, et al. Maternal human polyoma virus infection and risk of neuroblastoma in the child. Int J Cancer. 2005;113:393–396
  30. Rollison DE, Utaipat U, Ryschkewitsch C, Hou J, Goldthwaite P, Daniel R, et al. Investigation of human brain tumors for the presence of polyomavirus genome sequences by two independent laboratories. Int J Cancer. 2005;113:769–774
  31. Okamoto H, Mineta T, Ueda S, Nakahara Y, Shiraishi T, Tamiya T, et al. Detection of JC virus DNA sequences in brain tumors in pediatric patients. J Neurosurg. 2005;102(Suppl 3):294–298
  32. Kinlen LJ. Evidence for an infective cause of childhood leukaemia: comparison of a Scottish new town with nuclear reprocessing sites in Britain. Lancet. 1988;ii:1323–1327
  33. Kinlen LJ. Epidemiological evidence for an infective basis in childhood leukaemia. Br J Cancer. 1995;71:1–5
  34. Greaves MF. Speculations on the cause of childhood acute lymphoblastic leukaemia. Leukemia. 1988;2:120–125
  35. Gilham C, Peto J, Simpson J, Roman E, Eden TO, Greaves MF, et al. UKCCS Investigators, day care in infancy and risk of childhood acute lymphoblastic leukemia: findings from UK case-control study. Br Med J. 2005;330:1294
  36. Balta G, Yuksek N, Ozyurek E, Ertem U, Hicsonmez G, Altay C, et al. Characterization of MTHFR, GSTM1, GSTP1, and CYP1A1 genotypes in childhood acute leukemia. Am J Hematol. 2003;73:154–160
  37. Kracht T, Schrappe M, Strehl S, Reiter A, Elsner HA, Trka J, et al. NQO1 C609T polymorphism in distinct entities of pediatric hematologic neoplasms. Haematology. 2004;89:1492–1497
  38. Joseph T, Kusumakumary P, Chacko P, Abraham A, Radhakrishna PM. Genetic polymorphism of CYP1A1, CYP2D6, GSTM1, GSTT1 and susceptibility to acute lymphoblastic leukaemia in Indian children. Pediatr Blood Cancer. 2004;43:560–567
  39. Zielinska E, Zubowska M, Bodalski J. Polymorphism within the glutathione S-transferase P1 gene is associated with increased susceptibility to childhood malignant diseases. Pediatr Blood Cancer. 2004;43:552–559
  40. Canalle R, Burim RV, Tone LG, Takahashi CS. Genetic polymorphisms and susceptibility to childhood acute lymphoblastic leukemia. Environ Mol Mutagen. 2004;43:100–109
  41. Pakakasama S, Mukda E, Sasankul W, Kadegasem P, Udomsubpayakul U, Thithapandha A, et al. Polymorphisms of drug-metabolizing enzymes and risk of childhood acute lymphoblastic leukemia. Am J Hematol. 2005;79:202–205
  42. Gale KB, Ford AM, Repp R, Borkhardt A, Keller C, Eden OB, et al. Backtracking leukemia to birth: identification of clonotypic gene fusion sequences in neonatal blood spots. Proc Natl Acad Sci USA. 1997;94:13950–13954
  43. Ford AM, Bennett CA, Price CM, Bruin MC, Van Wering ER, Greaves M. Fetal origins of the TEL-AML1 fusion gene is identical twins with leukemia. Proc Natl Acad Sci USA. 1998;95:4584–4588
  44. Wiemels JL, Xiao Z, Buffler PA, Maia AT, Ma X, Dicks BM, et al. In utero origin of t(8:21) AML1-ETO translocations in childhood acute myeloid leukemia. Blood. 2002;99:3801–3805
  45. Greaves MF, Wiemels J. Origins of chromosome translocations in childhood leukemia. Nat Rev Cancer. 2003;3:639–649
  46. McHale CM, Smith MT. Prenatal origin of chromosome translocations in acute childhood leukemia: implications and future directions. Am J Hematol. 2004;75:254–257
  47. Smith MT, McHale CM, Wiemels JL, Zhang L, Wiencke JK, Zheng S, et al. Molecular markers for the study of childhood leukemia. Toxicol Appl Pharmacol. 2005;206:237–245
  48. Neri M, Fucic A, Knudsen LE, Lando C, Merlo F, Bonassi S. Micronuclei frequency in children exposed to environmental mutagens: a review. Mutat Res. 2003;544:243–254
  49. Neri M, Ugolini D, Bonassi S, Fucic A, Holland N, Knudsen LE, et al. Children’s exposure to environmental pollutants and biomarkers of genetic damage (II. Results of a comprehensive literature search and meta-analysis). Mutat Res. 2005;612:14–39
  50. Strick R, Strissel PL, Borgers S, Smith SL, Rowley JD. Dietary bioflavonoids induce cleavage in the MLL gene and may contribute to infant leukemia. Proc Natl Acad Sci USA. 2000;97:4790–4795
  51. Wiemels JL, Pagnamenta A, Taylor GM, Eden OB, Alexander FE, Greaves MF. A lack of a functional NAD(P)H:quinone oxidoreductase allele is selectively associated with pediatric leukemias that have MLL fusions (United Kingdom Childhood Cancer Study Investigators). Cancer Res. 1999;59:4095–4099
  52. Smith MT, Wang Y, Skibola CF, Slater DJ, Lo Nigro L, Nowell PC, et al. Low NAD(P)H:quinone oxidoreductase activity is associated with increased risk of leukemia with MLL translocations in infants and children. Blood. 2002;100:4590–4593
  53. Ross JA, Potter JD, Reaman GH, Pendergrass TW, Robison LL. Maternal exposure to potential inhibitors of DNA topoisomerase II and infant leukemia (United States): a report from the Children’s Cancer Group. Cancer Causes Control. 1996;7:581–590
  54. Ross JA. Maternal diet and infant leukemia: a role for DNA topoisomerase II inhibitors?. Int J Cancer. 1998;11:26–28
  55. Alexander FE, Patheal SL, Biondi A, Brandalise S, Cabrera ME, Chan LC, et al. Transplacental chemical exposure and risk of infant leukemia with MLL gene fusion. Cancer Res. 2001;61:2542–2546
  56. Ross JA. Dietary flavonoids and the MLL gene: a pathway to infant leukemia?. Proc Natl Acad Sci USA. 2000;97:4411–4413
  57. Spector LG, Xie Y, Robison LL, Heerema NA, Hilden JM, Lange B, et al. Maternal diet and infant leukemia: the DNA topoisomerase II inhibitor hypothesis: a report from the Children’s Oncology Group. Cancer Epidemiol Biomarkers Prev. 2005;14:651–655
  58. Paolini M, Sapone A, Valgimigli L. Avoidance of bioflavonoid supplements during pregnancy: a pathway to infant leukemia?. Mutat Res. 2003;527:99–101
  59. Boffetta P, Tredaniel J, Greco A. Risk of childhood cancer and adult lung cancer after childhood exposure to passive smoke: a meta-analysis. Environ Health Perspect. 2000;108:73–82
  60. Huncharek M, Kupelnick B, Klassen H. Maternal smoking during pregnancy and the risk of childhood brain tumors: a metaanalysis of 6566 subjects from twelve epidemiological studies. J Neurooncol. 2002;57:51–57
  61. Filippini G, Maisonneuve P, McCredie M, Peris-Bonet R, Modan B, Preston-Martin S, et al. Relation of childhood brain tumors to exposure of parents and children to tobacco smoke: the SEARCH international case-control study. Int J Cancer. 2002;100:206–213
  62. Chen Z, Robison L, Giller R, Krailo M, Davis M, Gardner K, et al. Risk of childhood germ cell tumors in association with parental smoking and drinking. Cancer. 2005;103:1064–1071
  63. Pang D, McNally R, Birch JM. Parental smoking and childhood cancer: results from the United Kingdom Childhood Cancer Study. Br J Cancer. 2003;88:373–381
  64. Coghlin J, Gann PH, Hammond SK, Skipper PL, Taghizadeh K, Paul M, et al. 4-Aminobiphenyl hemoglobin adducts in fetuses exposed to the tobacco smoke carcinogen in utero. J Natl Cancer Inst. 1991;83:274–280
  65. Lackmann GM, Salzberger U, Tollner U, Chen M, Carmella SG, Hecht SS. Metabolites of a tobacco-specific carcinogen in urine from newborns. J Natl Cancer Inst. 1999;91:459–465
  66. Hansen C, Asmussen I, Autrup H. Detection of carcinogen–DNA adducts in human fetal tissues by the 32P-postlabeling procedure. Environ Health Perspect. 1993;99:229–231
  67. Ammenheuser MM, Berenson AB, Stiglich NJ, Whorton EB, Ward JB. Elevated frequencies of hprt mutant lymphocytes in cigarette-smoking mothers and their newborns. Mutat Res. 1994;304:285–294
  68. Finette BA, O’Neill JP, Vacek PM, Albertini RJ. Gene mutations with characteristic deletions in cord blood T lymphocytes associated with passive maternal exposure to tobacco smoke. Nat Med. 1998;4:1144–1151
  69. Whyatt RM, Jedrychowski W, Hemminki K, Santella MR, Tsai WY, Yang K, et al. Biomarkers of polycyclic aromatic hydrocarbon-DNA damage and cigarette smoke exposure in paired maternal and newborn blood samples as a measure of differential susceptibility. Cancer Epidemiol Biomarkers Prev. 2001;10:581–588
  70. Keohavong P, Xi L, Day RD, Zhang L, Grant SG, Day BW, et al. HPRT gene alterations in umbilical cord blood T-lymphocytes in newborns of mothers exposed to tobacco smoke during pregnancy. Mutat Res. 2005;572:156–166
  71. de la Chica RA, Ribas I, Giraldo J, Ergozcue J, Fuster C. Chromosomal instability in amniocytes from fetuses of mothers who smoke. J Am Med Assoc. 2005;293:1212–1222
  72. DeMarini DM, Preston RJ. Smoking while pregnant (Transplacental mutagenesis of the fetus by tobacco smoke). J Am Med Assoc. 2005;293:1264–1265
  73. Perera F, Tang D, Whyatt R, Lederman SA, Jedrychowski W. DNA damage from polycyclic aromatic hydrocarbons measured by benzo[a]pyrene–DNA adducts in mothers and newborns from Northern Manhattan, the World Trade Center Area, Poland, and China. Cancer Epidemiol Biomarkers Prev. 2005;14:709–714
  74. Bocskay KA, Tang D, Orjeula MA, Liu X, Warburton DP, Perera FP. Chromosomal aberrations in cord blood are associated with prenatal exposure to carcinogenic polycyclic aromatic hydrocarbons. Cancer Epidemiol Biomarkers Prev. 2005;14:506–511
  75. Stjernfeldt M, Berglund K, Lindsten J, Ludvigsson J. Maternal smoking and irradiation during pregnancy as risk factors for child leukemia. Cancer Detect Prev. 1992;16:129–135
  76. Cole C. Registering childhood cancers. Lancet. 2004;364:2074–2076
  77. Lobdell DT, Mendola P. Development of a biomarkers database for the National Children’s Study. Toxicol Appl Pharmacol. 2005;206:269–273
  78. Zhu Y, Spitz MR, Amos CI, Lin J, Schabath MB, Wu X. An evolutionary perspective on single-nucleotide polymorphism screening in molecular cancer epidemiology. Cancer Res. 2004;64:2251–2257
  79. Xi T, Jones IM, Mohrenweiser HW. Many amino acid substitution variants identified in DNA repair genes during human population screenings are predicted to impact protein function. Genomics. 2004;83:970–979
  80. Infante-Rivard C, Mathonnet G, Sinnett D. Risk of childhood leukemia associated with diagnostic irradiation and polymorphisms in DNA repair genes. Environ Health Perspect. 2000;108:495–498
  81. Infante-Rivard C. Diagnostic X rays, DNA repair genes and childhood acute lymphoblastic leukemia. Health Phys. 2003;85:60–64
  82. Mathonnet G, Krajinovic M, Labuda D, Sinnett D. Role of DNA mismatch repair genetic polymorphisms in the risk of childhood acute lymphoblastic leukaemia. Br J Haematol. 2003;123:45–48
  83. Joseph T, Kusumakumary P, Chacko P, Abraham A, Pillai MR. DNA repair gene XRCC1 polymorphisms in childhood acute lymphoblastic leukemia. Cancer Lett. 2005;217:17–24
  84. Relton CL, Daniel CP, Hammal DM, Parker L, Tawn EJ, Burn J. DNA repair gene polymorphisms, pre-natal factors and the frequency of somatic mutations in the glycophorin-A gene among healthy newborns. Mutat Res. 2000;545:49–57
  85. Miller MS. Transplacental lung carcinogenesis: molecular mechanisms and pathogenesis. Toxicol Appl Pharmacol. 2004;198:95–110
  86. Lu LJ, Wang MY. Modulation of benzo[a]pyrene covalent DNA modifications in adult and fetal mice by gestation stage. Carcinogenesis. 1990;11:1367–1372
  87. Lu LJ, Anderson LM, Jones AB, Moskal TJ, Salazar JJ, Hokanson JA, et al. Persistence, gestation-stage dependent formation and interrelationship of benzo[a]pyrene-induced DNA adducts in mothers, placentae and fetuses of Erythrocebus patas monkeys. Carcinogenesis. 1993;14:1805–1813
  88. Choudhary D, Jansson I, Sarfarazi M, Schenkman JB. Xenobiotic-metabolizing cytochromes P450 in ontogeny: evolving perspective. Drug Metab Rev. 2004;236:549–568
  89. Blake MJ, Castro L, Leeder JS, Kearns GL. Ontogeny of drug metabolizing enzymes in the neonate. Semin Fetal Neonatal Med. 2005;10:123–138
  90. Vinson RK, Hales BF. DNA repair during organogenesis. Mutat Res. 2002;509:79–91
  91. Huncharek M, Kupelnick B, Klassen H. Paternal smoking during pregnancy and the risk of childhood brain tumors: results of a meta-analysis. In Vivo. 2001;15:535–541
  92. Brondum J, Shu XO, Steinbuch M, Severson RK, Potter JD, Robison LL. Parental cigarette smoking and the risk of acute leukemia in children. Cancer. 1999;85:1380–1388
  93. Ji BT, Shu XO, Linet MS, Zheng W, Wacholder S, Gao YT, et al. Paternal cigarette smoking and the risk of childhood cancer among offspring of nonsmoking mothers. J Natl Cancer Inst. 1997;89:238–244
  94. Maciag A, Bialkowska A, Espiritu I, Powell D, Alvord WG, Kasprzak KS, et al. Gestation-stage specific oxidative DNA damage from sidestream smoke in pregnant rats and their fetuses. Arch Environ Health. 2003;58:238–244
  95. Schuz J, Kaletsch U, Kaatsch P, Meinert R, Michaelis J. Risk factors for pediatric tumors of the central nervous system: results from a German population-based case-control study. Med Pediatr Oncol. 2001;36:274–282
  96. Cheng RYS, Birely LA, Lum NL, Perella CM, Cherry JM, Bhat NK, et al. Expressions of hepatic genes, especially IGF-binding protein 1, correlating with serum corticosterone in microarray analysis. J Mol Endocrinol. 2004;32:257–278
  97. Cheng RYS, Alvord WG, Powell D, Kasprzak KS, Anderson LM. Increased serum corticosterone and glucose in offspring of chromium(III)-treated male mice. Environ Health Perspect. 2002;110:801–804
  98. Cheng RYS, Hockman T, Crawford E, Anderson LM, Shiao YH. Epigenetic and gene expression changes related to trans-generational carcinogenesis. Mol Carcinog. 2004;40:1–11
  99. Shiao YH, Crawford EB, Anderson LM, Patel P, Ko K. Allele-specific germ cell epimutation in the spacer promoter of the 45S ribosomal RNA gene after Cr(III) exposure. Toxicol Appl Pharmacol. 2005;205:290–296
  100. Toth B. A critical review of experiments in chemical carcinogenesis using newborn animals. Cancer Res. 1968;28:727–738
  101. Mirvish S, Cividalli G, Berenblum I. Slow elimination of urethan in relation to its high carcinogenicity in newborn mice. Proc Soc Exp Biol Med. 1964;116:265–268
  102. Nomura T. Long retention of urethan transferred into newborn mice transplacentally, as a possible cause of high carcinogenesis. Gann. 1973;64:29–40
  103. Higinbotham KG, Rice JM, Reed CD, Watatani M, Enomoto T, Anderson LM, et al. Variant mutational activation of the K-ras oncogene in renal mesenchymal tumors induced in newborn F344 rats by methyl(methoxymethyl)nitrosamine. Carcinogenesis. 1996;17:2625–2630
  104. Wislocki PG, Bagan ES, Lu AY, Dooley KL, Fu PP, Han-Hsu H, et al. Tumorigenicity of nitrated derivatives of pyrene, benz[a]anthracene, chrysene and benzo[a]pyrene in the newborn mouse assay. Carcinogenesis. 1986;7:1317–1322
  105. Miyauchi M, Nishikawa A, Furukawa F, Kasahara K, Nakamura H, Takahashi M, et al. Carcinogenic risk assessment of MeIQx and PhIP in a newborn mouse two-stage tumorigenesis assay. Cancer Lett. 1999;142:75–81
  106. Newbold RR. Lessons learned from perinatal exposure to diethylstilbestrol. Toxicol Appl Pharmacol. 2004;199:142–150
  107. Coccia P, Salmona M, Diomede L, Citti L, Mariani L, Romano M. Liver DNA alkylation after a single carcinogenic dose of dimethylnitrosamine to newborn and adult CFW Swiss mice. Chem Biol Interact. 1988;68:259–271
  108. Korte JE, Hertz-Picciotto I, Schulz MR, Ball LM, Duell EJ. The contribution of benzene to smoking-induced leukemia. Environ Health Perspect. 2000;108:333–339
  109. Eastman DA, Mondrala ST, Hasegawa L. Topoisomerase II inhibition by myeloperoxidase-activated hydroquinone: a potential mechanism underlying the genotoxic and carcinogenic effects of benzene. Chem Biol Interact. 2005;153–154207-16
  110. Keller KA, Snyder CA. Mice exposed in utero to 20 ppm benzene exhibit altered numbers of recognizable hematopoietic cells up to seven weeks after exposure. Fundam Appl Toxicol. 1988;10:224–232
  111. Ning H, Kado NY, Kuzmicky PA, Hsieh DP. Benzene-induced micronuclei formation in mouse fetal liver blood, peripheral blood, and maternal bone marrow cells. Environ Mol Mutagen. 1991;18:1–5
  112. Xing SG, Shi X, Wu ZL, Chen JK, Wallace W, Whong WZ, et al. Transplacental genotoxicity of triethylenemelamine, benzene, and vinblastine in mice. Teratog Carcinog Mutagen. 1992;12:223–230
  113. Crosignani P, Tittarelli A, Borgini A, Codazzi T, Rovelli A, Porro E, et al. Childhood leukemia and road traffic: a population-based case-control study. Int J Cancer. 2004;108:596–599
  114. Steffen C, Auclerc MF, Auvrignon A, Baruchel A, Kebaili K, Lambilliotte A, et al. Acute childhood leukaemia and environmental exposure to potential sources of benzene and other hydrocarbons: a case-control study. Occup Environ Med. 2004;61:773–778
  115. Knox EG. Childhood cancers and atmospheric carcinogens. J Epidemiol Commun Health. 2005;59:101–105
  116. Christian MS. Review of reproductive and developmental toxicity of 1,3-butadiene. Toxicology. 1996;113:137–143
  117. Mori H, Colman SM, Xiao Z, Ford AM, Healy LE, Donaldson C, et al. Chromosomal translocations and covert leukemic clones are generated during normal fetal development. Proc Natl Acad Sci USA. 2002;99:8242–8247
  118. Anderson LM, Chhabra SK, Nerurkar PV, Souliotis VL, Kyrtopoulos SA. Alcohol-related cancer risk: a toxicokinetic hypothesis. Alcohol. 1995;12:97–104
  119. Chhabra SK, Souliotis VL, Harbaugh JW, Kras-now SW, Jones AB, Anderson LM, et al. O6Methylguanine DNA adduct formation and modulation by ethanol in placenta and fetal tissues after exposure of pregnant patas monkeys to N-nitrosodimethylamine. Cancer Res. 1995;55:6017–6020
  120. Walker BE. Tumors in female offspring of control and diethylstilbestrol-exposed mice fed high-fat diets. J Natl Cancer Inst. 1990;82:50–54
  121. Rice JM. Causation of nervous system tumors in children: insights from traditional and genetically engineered animal models. Toxicol Appl Pharmacol. 2004;199:175–191
  122. Raffel C. Medulloblastoma: molecular genetics and animal models. Neoplasia. 2004;6:310–322
  123. Wetmore C, Eberhart DE, Curran T. The normal patched allele is expressed in medulloblastomas from mice with heterozygous germ-line mutation of patched. Cancer Res. 2000;60:2239–2246
  124. Pazzaglia S, Mancuso M, Atkinson MJ, Tanori M, Rebessi S, Majo VD, et al. High incidence of medulloblastoma following X-ray-irradiation of newborn Ptc1 heterozygous mice. Oncogene. 2002;21:7580–7584
  125. Grufferman S, Wang HH, DeLong ER, Kimm SY, Delzell ES, Falletta JM. Environmental factors in the etiology of rhabdomyosarcoma in childhood. J Natl Cancer Inst. 1982;68:107–113
  126. McCredie M, Maisonneuve P, Boyle P. Antenatal risk factors for malignant brain tumors in New South Wales children. Int J Cancer. 1994;56:6–10
  127. Shu XO, Ross JA, Pendergrass TW, Reaman GH, Lampkin B, Robison LL. Parental alcohol consumption, cigarette smoking, and risk of infant leukemia: a Children’s Cancer Group study. J Natl Cancer Inst. 1996;88:24–31
  128. Sorahan T, Lancashire RJ, Hulten MA, Peck I, Stewart AM. Childhood cancer and parental use of tobacco: deaths from 1953 to 1955. Br J Cancer. 1997;75:134–138
  129. Sorahan T, Prior P, Lancashire RJ, Faux SP, Hulten MA, Peck IM, et al. Childhood cancer and parental use of tobacco: deaths from 1971 to 1976. Br J Cancer. 1997;76:1525–1531
  130. Sorahan T, McKinney PA, Mann JR, Lancashire RJ, Stiller CA, Birch JM, et al. Childhood cancer and parental use of tobacco: findings from the inter-regional epidemiological study of childhood cancer (IRESCC). Br J Cancer. 2001;84:141–146
  131. Cordier S, Monfort C, Filippini G, Preston-Martin S, Lubin F, Mueller BA, et al. Parental exposure to polycyclic aromatic hydrocarbons and the risk of childhood brain tumors: the SEARCH International Childhood Brain Tumor Study. Am J Epidemiol. 2004;159:1109–1116
  132. John EM, Savitz DA, Sandler DP. Prenatal exposure to parents’ smoking and childhood cancer. Am J Epidemiol. 1991;133:123–132
  133. Norman MA, Holly EA, Ahn DK, Preston-Martin S, Mueller BA, Bracci PM. Prenatal exposure to tobacco smoke and childhood brain tumors: results from the United States West Coast Childhood Brain Tumor Study. Cancer Epidemiol Biomarkers Prev. 1996;5:127–133
  134. Yang Q, Olshan AF, Bondy ML, Shah NR, Pollock BH, Seeger RC, et al. Parental smoking and alcohol consumption and risk of neuroblastoma. Cancer Epidemiol Biomarkers Prev. 2000;9:967–972
  135. Hu J, Mao Y, Ugnat AM. Parental cigarette smoking, hard liquor consumption and risk of childhood brain tumors. Acta Oncol. 2000;39:979–984

 This article is an excerpt of one published in Mutation Research 2006;608:136-56.

PII: S1538-5442(07)00103-4

doi: 10.1016/j.cppeds.2007.11.002

Current Problems in Pediatric and Adolescent Health Care
Volume 38, Issue 2 , Pages 50-63 , February 2008

Article Tools